Literature DB >> 11264190

Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells.

M L Guzman1, D Upchurch, B Grimes, D S Howard, D A Rizzieri, S M Luger, G L Phillips, C T Jordan.   

Abstract

Previous studies indicate that human acute myelogenous leukemia (AML) arises from a rare population of leukemic stem cells. Cells of this nature can initiate and maintain leukemic cell growth in both long-term cultures and nonobese diabetic/severe combined immune-deficient mice. To characterize the biology of primitive AML cells, gene expression screens were performed with 7 primary AML and 3 normal specimens. For each sample, stem cell populations (CD34(+)/CD38(-)) were isolated and used to synthesize radiolabeled complementary DNA (cDNA). AML vs normal probes were then hybridized to cDNA arrays containing genes related to cancer and apoptosis. Of approximately 1400 genes analyzed, 2 tumor-suppressor genes were identified that were overexpressed in all 7 of the AML CD34(+)/CD38(-) cell populations: death-associated protein kinase and interferon regulatory factor 1. Expression of each gene was confirmed by reverse-transcription polymerase chain reaction and immunoblot analysis. It is proposed that tumor-suppressor proteins play a role in the biology of primitive AML cells. (Blood. 2001;97:2177-2179)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264190     DOI: 10.1182/blood.v97.7.2177

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Reactive oxygen species in eradicating acute myeloid leukemic stem cells.

Authors:  Hui Zhang; Hai Fang; Kankan Wang
Journal:  Stem Cell Investig       Date:  2014-06-07

2.  Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation.

Authors:  E M Coccia; E Stellacci; M Valtieri; B Masella; T Feccia; G Marziali; J Hiscott; U Testa; C Peschle; A Battistini
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

3.  A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.

Authors:  Dianna S Howard; Jane Liesveld; Gordon L Phillips; John Hayslip; Heidi Weiss; Craig T Jordan; Monica L Guzman
Journal:  Leuk Res       Date:  2013-09-08       Impact factor: 3.156

4.  The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.

Authors:  Monica L Guzman; Randall M Rossi; Lilliana Karnischky; Xiaojie Li; Derick R Peterson; Dianna S Howard; Craig T Jordan
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

5.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

6.  Preferential induction of apoptosis for primary human leukemic stem cells.

Authors:  Monica L Guzman; Carol F Swiderski; Dianna S Howard; Barry A Grimes; Randall M Rossi; Stephen J Szilvassy; Craig T Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

7.  Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors.

Authors:  Auxiliadora Aracil-Fernández; José M Trigo; María S García-Gutiérrez; Antonio Ortega-Álvaro; Alexander Ternianov; Daniela Navarro; Patricia Robledo; Pere Berbel; Rafael Maldonado; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

8.  The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression.

Authors:  Mehtap S Gündogdu; He Liu; Daniela Metzdorf; Dagmar Hildebrand; Michael Aigner; Klaus Aktories; Klaus Heeg; Katharina F Kubatzky
Journal:  Mol Cancer       Date:  2010-08-25       Impact factor: 27.401

9.  An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

Authors:  Monica L Guzman; Randall M Rossi; Sundar Neelakantan; Xiaojie Li; Cheryl A Corbett; Duane C Hassane; Michael W Becker; John M Bennett; Edmund Sullivan; Joshua L Lachowicz; Andrew Vaughan; Christopher J Sweeney; William Matthews; Martin Carroll; Jane L Liesveld; Peter A Crooks; Craig T Jordan
Journal:  Blood       Date:  2007-09-05       Impact factor: 22.113

10.  Mannose-exposing myeloid leukemia cells detected by the sCAR-PPA fusion protein.

Authors:  Gong Chu Li; Na Li; Yan Hong Zhang; Xin Li; Yi Gang Wang; Xin Yuan Liu; Wen Bin Qian; Xiao Chuan Liu
Journal:  Int J Hematol       Date:  2009-04-18       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.